Synthetic super-enhancers enable precision viral immunotherapy

A study published in Nature demonstrates that synthetic super-enhancers can precisely deliver anticancer payloads, eliminating tumors in a mouse model of glioblastoma. This breakthrough could advance precision viral immunotherapy for aggressive cancers.